Medicus Pharma Ltd. (MDCX) has 5 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 8, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 8, 2026 filed Sept. 4, 2026 | Smith Andrew Alasdair Chief Operating Officer | $125,368 | 860,294 | — | No | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 4, 2026 | Mehmud Faisal Chief Medical Officer | $250,735 | 1,720,588 | — | No | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 4, 2026 | Brennan Edward J. Chief Scientific Officer | $100,294 | 688,235 | — | No | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 4, 2026 | Bonner Carolyn F. President and CFO | $250,735 | 1,720,588 | — | No | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 4, 2026 | Bokhari Raza Chief Executive Officer | $501,471 | 3,441,176 | — | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free